Raj Jhaveri

Raj Jhaveri has a diverse work experience with expertise in technology, product management, and investment.

Raj began their career in 2015 as the Co-Founder and Chief Technology Officer of Face2Face Health, where they played a crucial role in the company's growth and development. In 2018, they transitioned to the role of Co-Founder and Chief Technical Advisor.

In 2016, Raj joined General Catalyst Partners as an Industry Consultant, specializing in healthcare and digital health-related investments. Raj provided valuable insights and advisory services to drive successful investment decisions until 2021.

In 2018, Raj took on the role of Senior Product Leader at EV Connect, a leading provider of electric vehicle charging solutions. Raj was responsible for product management, technology development, and integration, as well as technical business development.

Throughout their career, Raj has also been involved in various organizations and initiatives. Raj served as a Technical Board Member at the Alliance for Transportation Electrification (ATE), a Technical Committee Member at the Open Charge Alliance, and an Adjunct Professor at the University of California, Los Angeles (UCLA).

In 2020, Raj joined The Knowledge Society (TKS) as a Director. TKS is an accelerator designed for students aged 13-17, empowering them to explore emerging technologies and develop leadership skills.

Raj has been an active investor as well. Raj invested in EV Connect, Notch Interfaces Inc, Impossible Foods, and 23andMe, participating in their Series B, Series E, Series F funding rounds.

Overall, Raj Jhaveri's work experience showcases their strong technical expertise, leadership abilities, and passion for technology and innovation.

Raj Jhaveri's education history includes a Bachelor of Science degree in Mathematics and Biology from The Ohio State University, which was obtained from 2002 to 2006. Then, from 2007 to 2009, they pursued two concurrent degrees: a Master of Science in Medical Sciences from Harvard Medical School and completed studies in Biomedical/Medical Engineering from the Massachusetts Institute of Technology. Currently, they are enrolled in The Wharton School, pursuing an Executive MBA with a focus on Strategic Management and Innovation & Entrepreneurship, which started in 2021 and is expected to end in 2023.